IL5 and congenital rubella syndrome: The safety and tolerance of anti-IL-5 agents have been established in studies for the treatment of asthma and CRS.59, 60 Anti-IL-5s are safe and well-tolerated, with the most common side effects being headache, injection site reactions, back pain, and fatigue.59